Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cabergoline in Nonfunctioning Pituitary Adenoma
NCT07034859Phase 4Enrolling by invitation
- Sponsor
- National Taiwan University Hospital
- Start
- May 2024
- Primary completion
- Oct 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of cabergoline, sponsored by National Taiwan University Hospital. Started May 2024; status: enrolling by invitation.
02
Drugs
cabergoline
Beyond the preview
Go deeper on NCT07034859.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07034859.